New pricing regulations may restrict access to innovative drugs in Canada

Authors:

Bacchus BaruaKristina M.L. Acri, née Lybecker

Review board’s new reference countries have more limited access to new and innovative drugs.Read more about New pricing regulations may restrict access to innovative drugs in CanadaTags: pharmaceuticalsprescription drugsaccess to new drugspharmaceutical innovationpatientscancer medicine

Read More - The Fraser Institute